Author
Listed:
- Arnaud Bourdin
(PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] - INSERM - Institut National de la Santé et de la Recherche Médicale - CNRS - Centre National de la Recherche Scientifique - UM - Université de Montpellier, CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier])
- Nicolas Malafaye
(UM - Université de Montpellier, CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier])
- Joana Pissarra
(CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier])
- Engi Ahmed
(PhyMedExp - Physiologie & médecine expérimentale du Cœur et des Muscles [U 1046] - INSERM - Institut National de la Santé et de la Recherche Médicale - CNRS - Centre National de la Recherche Scientifique - UM - Université de Montpellier, CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier])
- Erika Nogué
(CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier])
- Carey Meredith Suehs
(CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier])
- Isabelle Vachier
(CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier])
- Nicolas Molinari
(IDESP - Institut Desbrest d'Epidémiologie et de Santé Publique - INSERM - Institut National de la Santé et de la Recherche Médicale - UM - Université de Montpellier, PREMEDICAL - Médecine de précision par intégration de données et inférence causale - CRISAM - Centre Inria d'Université Côte d'Azur - Inria - Institut National de Recherche en Informatique et en Automatique - IDESP - Institut Desbrest d'Epidémiologie et de Santé Publique - INSERM - Institut National de la Santé et de la Recherche Médicale - UM - Université de Montpellier, CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier])
Abstract
No abstract is available for this item.
Suggested Citation
Arnaud Bourdin & Nicolas Malafaye & Joana Pissarra & Engi Ahmed & Erika Nogué & Carey Meredith Suehs & Isabelle Vachier & Nicolas Molinari, 2025.
"Healthcare Resource Utilisation and Costs of Mepolizumab Initiation: A 5‐Year National Cohort Analysis,"
Post-Print
hal-04950053, HAL.
Handle:
RePEc:hal:journl:hal-04950053
DOI: 10.1111/all.16501
Note: View the original document on HAL open archive server: https://hal.science/hal-04950053v1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:hal:journl:hal-04950053. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: CCSD (email available below). General contact details of provider: https://hal.archives-ouvertes.fr/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.